tass.ru - MONKEYPOX OUTBREAK - MAY 27, 10:44 AM - Moscow

Russia called on WHO leadership to investigate the activities of US-funded Nigerian laboratories in Abuja, Zaria, and Lagos

At least four US-controlled Biolabs operate in Nigeria, where monkeypox originated. This was stated on Friday by the head of the troops of radiation, chemical, and biological protection (RCBZ) of the Armed Forces of Russia Igor Kirillov.

He recalled that, according to a report by the World Health Organization (WHO), the West African strain of monkeypox was introduced from Nigeria, where the United States has placed its biological infrastructure.

"According to the available information, there are at least four biological laboratories controlled by Washington in Nigeria," Kirillov said.

According to him, in this regard, one should recall a strange coincidence that needs additional verification by specialists.

“So, according to European and American media, in the materials of the Munich Security Conference 2021, that is, against the backdrop of the COVID-19 pandemic, a scenario was worked out to counter an outbreak caused by a new strain of the monkeypox virus,” said the head of the troops.

According to Kirillov, Russia is calling on the WHO leadership to investigate the activities of US-funded Nigerian laboratories in Abuja, Zaria, and Lagos.

“Against the backdrop of numerous cases of US violations of biosecurity requirements and facts of careless storage of pathogenic biomaterials, we call on the leadership of the World Health Organization to conduct an investigation into the activities of US-funded Nigerian laboratories in Abuja, Zaria, Lagos and inform the world community about its results,” he said.

According to the Defense Department slides for the briefing, two US-controlled biological laboratories operate in the city of Abuja, one in the city of Zaria and one in Lagos.

Follow our news on Telegram, VKontakte, and Odnoklassniki.

Monkeypox Vaccine Funded By Fauci Was Approved By The FDA in 2019

newspunch - Fact checked Niamh Harris

The spread of monkeypox has boosted the shares of a Danish biotech company called Bavarian Nordic A/S, which says it’s the only one to make a vaccine approved for the viral infection.

According to CEO Paul Chaplin, Bavarian Nordic has already received requests from dozens of countries who are seeking the vaccine and confirmed the company had secured a contract to supply the shot to an unnamed country in Europe.“Monkeypox” – who could have seen that coming?

Well take a look at who funded Bavarian Nordic…. none other than Dr. Anthony Fauci

And look at some of the shareholders…notably Vanguard and BlackRock.

Dr. Sam Bailey reports: As with COVID-19, it appears that other parties have also been eagerly awaiting a market such a “pandemic” would present. Likewise, these fortune-tellers were preparing vaccines to go where no vaccine had gone before. In this case, the biotech company Bavarian Nordic gained approval from the FDA in 2019 to market JYNNEOS, smallpox, and monkeypox vaccine. Other health authorities were also primed to react to a previously rare condition that has been of no concern for their nations…until now apparently. For example, on May 20, 2022, the UK Health Security Agency published a document titled, “Recommendations for the use of pre and post-exposure vaccination during a monkeypox incident.” Like COVID-19, it’s starting to feel like all roads lead to vaccines again…

Just a matter of time before the “rare” monkeypox vaccine comes to your neighborhood.

So now that the scene has been set we can get into the “science” of monkeypox starting with an official description of the alleged viral disease. The CDC states, “Monkeypox was first discovered in 1958 when two outbreaks of a pox-like disease occurred in colonies of monkeys kept for research, hence the name ‘monkeypox.’ The first human case of monkeypox was recorded in 1970 in the Democratic Republic of Congo.” They go on to state, “In humans, the symptoms of monkeypox are similar to but milder than the symptoms of smallpox.” The illness is said to be flu-like with the addition of lymph node swelling and the development of a rash, and then lesions that progress from macules to vesicles to scabs.

In terms of the lethality of monkeypox, the CDC state that, “in Africa, monkeypox has been shown to cause death in as many as 1 in 10 persons who contract the disease.” This 10% fatality rate has already stoked the fear narrative and was also used as the case fatality rate in the NTI’s monkeypox pipe dream. It should be noted that historically monkeypox has been virtually unheard of in first-world countries and the rare cases are usually in people that have recently arrived from Africa.

Indeed, one of the only recorded “outbreaks” of monkeypox in the first world was in the United States in April 2003. Cases were declared in 6 states and said to be caused by rodents that were imported to Texas from Ghana. This was the first time monkeypox had been reported outside of Africa and the CDC published a paper in 2006 analyzing the incident. The paper states that “person-to-person spread of the virus is thought to occur principally via infectious oropharyngeal exudates” although it is clear that this has never been scientifically established. They continue to say that, “the virus is thought to have been transmitted from African animals” – in other words, it’s another species-jumping pathogen tale.

They reported that “individuals who had illness onset within 21 days after exposure to MPXV [Monkeypox virus] who experienced fever (defined as a body temperature greater 37.4°C) and vesicular pustular rash or rash (potentially uncharacterized) plus orthodox IgM antibodies were classified as having probable cases of infection.” Now 37.4°C is not a fever in our book, it is a normal body temperature and we would suggest 37.6°C and above qualifies as a fever. We noted in their chart that they were using the classification ≥39.4°C, but this appears to be an error as in another paper, we’ll get to soon, it was once again 37.4°C.

The second paper even said the “fever” could be subjective, so they appear to be using this loose criterion and pathologizing a normal state. Additionally, the CDC’s weekly report from the 11th of July 2003, stated that from a total of 71 cases, only “two patients, both children, had a serious clinical illness; both of these patients have recovered.” The remainder had a variety of respiratory and gastrointestinal symptoms.

The CDC’s cases were confirmed on the basis of specimens that showed, “monkeypox virus isolation, detection of monkeypox-specific nucleic acid signatures, positive electron-microscopy findings, or positive immuno-histo-chemical findings.” We had a look at the electron micrographs presented by the CDC including the image shown below of a skin sample from one of the patients.

The caption informs us that the round particles on the right are immature monkeypox virions, while the oval particles on the left are mature viruses. However, all they have is a static image of dead tissue and no conclusions can be made about the biological role of the imaged particles. None of them have been shown to be replication-competent disease-causing intracellular parasites and so should not be called ‘viruses’.

Continue reading here (long article)

COPYRIGHTS

Copy & Paste the link above for Yandex translation to Norwegian.

WHO and WHAT is behind it all? : >

The bottom line is for the people to regain their original, moral principles, which have intentionally been watered out over the past generations by our press, TV, and other media owned by the Illuminati/Bilderberger Group, corrupting our morals by making misbehavior acceptable to our society. Only in this way shall we conquer this oncoming wave of evil.

Commentary:

Administrator

HUMAN SYNTHESIS

All articles contained in Human-Synthesis are freely available and collected from the Internet. The interpretation of the contents is left to the readers and do not necessarily represent the views of the Administrator. Disclaimer: The contents of this article are of the sole responsibility of the author(s). Human-Synthesis will not be responsible for any inaccurate or incorrect statement in this article. Human-Synthesis grants permission to cross-post original Human-Synthesis articles on community internet sites as long as the text & title are not modified